tiprankstipranks
Trending News
More News >
Lakeshore Biopharma Co., Ltd (LSB)
:LSB
US Market
Advertisement

LakeShore Biopharma (LSB) Ratios

Compare
94 Followers

LakeShore Biopharma Ratios

LSB's free cash flow for Q4 2024 was ¥0.25. For the 2024 fiscal year, LSB's free cash flow was decreased by ¥ and operating cash flow was ¥-0.69. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.02 1.13 1.57 7.20 10.47K
Quick Ratio
0.75 0.87 1.29 -1.16K 9.31K
Cash Ratio
0.03 0.31 0.56 6.21 5.58K
Solvency Ratio
-0.07 -0.42 -0.11 1.50 -2.34K
Operating Cash Flow Ratio
-0.15 -0.37 -0.28 -4.30 -3.52K
Short-Term Operating Cash Flow Coverage
-0.31 -0.93 -0.94 >-0.01 0.00
Net Current Asset Value
¥ -25.69M¥ -24.65M¥ 44.68M¥ -19.33M¥ 733.13M
Leverage Ratios
Debt-to-Assets Ratio
0.30 0.28 0.29 1.89 0.05
Debt-to-Equity Ratio
0.83 0.73 0.68 2.11 0.23
Debt-to-Capital Ratio
0.45 0.42 0.41 0.68 0.19
Long-Term Debt-to-Capital Ratio
0.04 0.14 0.29 0.58 0.98
Financial Leverage Ratio
2.74 2.59 2.36 1.11 4.28
Debt Service Coverage Ratio
-0.12 -0.96 -0.35 -0.63 -4.52
Interest Coverage Ratio
-5.48 -10.05 -4.52 -0.20 -4.24
Debt to Market Cap
1.71 0.07 0.06 0.02 <0.01
Interest Debt Per Share
0.00 4.38 6.84 12.99 1.03
Net Debt to EBITDA
-7.96 -0.48 -1.67 -5.65 3.34
Profitability Margins
Gross Profit Margin
82.47%79.48%77.68%76.72%76.79%
EBIT Margin
-13.85%-71.65%-16.51%-19.55%-56.29%
EBITDA Margin
-7.89%-64.29%-11.18%-13.36%-45.44%
Operating Profit Margin
-14.03%-77.75%-20.28%-0.11%-48.96%
Pretax Profit Margin
-16.41%-79.38%-21.00%-0.11%-67.84%
Net Profit Margin
-16.26%-75.59%-21.17%-0.11%-74.64%
Continuous Operations Profit Margin
-16.26%-75.59%-21.17%-21.08%-74.64%
Net Income Per EBT
99.06%95.23%100.79%100.00%110.01%
EBT Per EBIT
116.96%102.10%103.56%99.37%138.56%
Return on Assets (ROA)
-7.31%-28.65%-8.46%-0.27%-209935.26%
Return on Equity (ROE)
-18.43%-74.07%-19.97%-0.30%-897894.79%
Return on Capital Employed (ROCE)
-15.89%-62.72%-13.14%-0.27%-589064.49%
Return on Invested Capital (ROIC)
-9.15%-41.04%-11.15%-1.74%-18.78%
Return on Tangible Assets
-7.72%-30.06%-8.86%-0.45%229.22%
Earnings Yield
--7.73%-1.71%>-0.01%-1.07%
Efficiency Ratios
Receivables Turnover
1.23 1.28 1.48 1.63 1.04
Payables Turnover
2.17 1.74 1.91 3.80 3.64
Inventory Turnover
0.47 0.58 0.83 0.70 0.73
Fixed Asset Turnover
1.48 1.19 1.18 0.89 1.01
Asset Turnover
0.45 0.38 0.40 2.50 2.81K
Working Capital Turnover Ratio
10.39 2.40 3.64 1.37 0.00
Cash Conversion Cycle
900.81 705.33 495.71 647.01 750.41
Days of Sales Outstanding
297.83 284.63 245.95 223.92 352.37
Days of Inventory Outstanding
770.80 630.90 441.21 519.15 498.28
Days of Payables Outstanding
167.82 210.20 191.45 96.07 100.24
Operating Cycle
1.07K 915.53 687.16 743.07 850.64
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 -2.76 -2.36 -0.02 -8.58
Free Cash Flow Per Share
0.00 -3.17 -3.09 -10.15 -12.23
CapEx Per Share
0.00 0.41 0.74 10.13 3.65
Free Cash Flow to Operating Cash Flow
1.15 1.15 1.31 488.48 1.43
Dividend Paid and CapEx Coverage Ratio
-6.77 -6.67 -3.20 >-0.01 -2.35
Capital Expenditure Coverage Ratio
-6.77 -6.67 -3.20 >-0.01 -2.35
Operating Cash Flow Coverage Ratio
-0.29 -0.70 -0.37 >-0.01 -49.22K
Operating Cash Flow to Sales Ratio
-0.20 -0.51 -0.27 >-0.01 -0.96
Free Cash Flow Yield
-57.45%-6.06%-2.82%-1.65%-1.97%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
0.00 -12.93 -58.47 -33.29K -93.10
Price-to-Sales (P/S) Ratio
0.39 9.77 12.38 36.12 69.49
Price-to-Book (P/B) Ratio
0.00 9.58 11.68 100.54 835.94K
Price-to-Free Cash Flow (P/FCF) Ratio
-1.74 -16.51 -35.52 -60.65 -50.81
Price-to-Operating Cash Flow Ratio
0.00 -18.98 -46.62 -29.62K -72.42
Price-to-Earnings Growth (PEG) Ratio
0.00 -0.11 >-0.01 333.81 0.00
Price-to-Fair Value
0.00 9.58 11.68 100.54 835.94K
Enterprise Value Multiple
-12.94 -15.69 -112.44 -276.00 -149.59
Enterprise Value
628.00M 5.78B 8.64B 18.55B 17.47B
EV to EBITDA
-12.94 -15.69 -112.44 -276.00 -149.59
EV to Sales
1.02 10.08 12.57 36.87 67.97
EV to Free Cash Flow
-4.52 -17.03 -36.05 -61.91 -49.70
EV to Operating Cash Flow
-5.19 -19.59 -47.32 -30.24K -70.84
Tangible Book Value Per Share
0.00 4.81 8.40 3.39 -2.91
Shareholders’ Equity Per Share
0.00 5.47 9.41 6.12 <0.01
Tax and Other Ratios
Effective Tax Rate
<0.01 0.05 >-0.01 -9.05 -0.10
Revenue Per Share
0.00 5.36 8.88 17.05 8.94
Net Income Per Share
0.00 -4.05 -1.88 -0.02 -6.67
Tax Burden
0.99 0.95 1.01 1.00 1.10
Interest Burden
1.18 1.11 1.27 <0.01 1.21
Research & Development to Revenue
0.24 0.53 0.46 0.42 0.37
SG&A to Revenue
0.22 0.26 0.12 0.21 0.54
Stock-Based Compensation to Revenue
0.02 0.02 <0.01 0.02 0.30
Income Quality
1.21 0.68 1.25 1.12 1.29
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis